Coronary artery calcium score and N-terminal pro-B-type natriuretic peptide as potential gatekeepers for myocardial perfusion imaging

被引:1
|
作者
Haarmark, Christian [1 ,2 ]
Andersen, Kim Francis [3 ]
Madsen, Claus [1 ]
Zerahn, Bo [1 ]
机构
[1] Univ Hosp Copenhagen, Herlev & Gentofte Hosp, Dept Clin Physiol & Nucl Med, Herlev, Denmark
[2] Univ Hosp Copenhagen, Bispebjerg Hosp, Dept Clin Physiol & Nucl Med, Herlev, Denmark
[3] Univ Hosp Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark
关键词
Tc-99m-sestamibi; coronary artery calcium; Coronary heart disease; myocardial perfusion imaging; SPECT; AMERICAN-HEART-ASSOCIATION; COMPUTED-TOMOGRAPHY; TASK-FORCE; CARDIOVASCULAR ANGIOGRAPHY; NUCLEAR CARDIOLOGY; DISEASE; PREDICTION; SOCIETY; RISK; GUIDELINES;
D O I
10.1111/cpf.12363
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Myocardial perfusion imaging (MPI) holds an important place as non-invasive risk assessment in patients with intermediate risk of coronary heart disease (CHD). However, as much as 60-70% of MPI scans are normal. This study evaluates the role of coronary artery calcium scoring (CAC score) and NT-proBNP as potential gatekeepers for MPI. Patients with intermediate risk of CHD referred for standard MPI were included. CAC score and NT-proBNP were both assessed at the day of the stress study. Sensitivity, specificity and NPV for prediction of abnormal MPI scans were calculated for CAC, NT-proBNP and the combination hereof. A total of 190 patients were included (mean age 61 +/- 12 years, 55% female) of whom 24% had known CHD. In all 30% of the scans were abnormal. CAC score achieved the highest AUC regardless of whether patients with known CHD were included or not [AUC 0.75 95% CI (0.66-0.84) and AUC 0.79 (0.68-0.91)]. As a singular variable, CAC score was the most potent predictor with a sensitivity of 85%, specificity of 39% and NPV 88%. The combination of CAC score<10 and NT-proBNP>26 reached a sensitivity of 98% and NPV 94%, where 8% of scans tentatively could be avoided. In patients referred for MPI with intermediate risk for CHD, a combination of CAC score and NT-proBNP could be used to identify a group of patients where MPI could be averted with a high degree of diagnostic safety.
引用
收藏
页码:710 / 716
页数:7
相关论文
共 50 条
  • [1] Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes
    Coppola, Giuseppe
    Corrado, Egle
    Mule, Maria Cristina
    Augugliaro, Stefano
    Cucchiara, Angela
    Novo, Giuseppina
    Amoroso, Gisella
    Assennato, Pasquale
    Hoffmann, Enrico
    Vitale, Francesco
    Novo, Salvatore
    CORONARY ARTERY DISEASE, 2009, 20 (03) : 225 - 229
  • [2] Utility of Preoperative N-Terminal Pro-B-Type Natriuretic Peptide in the Prognosis of Coronary Artery Bypass Grafting
    Wang, Juncheng
    Liu, Hanning
    Zeng, Juntong
    Su, Xiaoting
    Zhao, Yan
    Zheng, Zhe
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 201 : 131 - 138
  • [3] Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
    Ribeiro, Demostenes G. L.
    Silva, Ricardo P.
    Barboza, Daniella R. M. M.
    Lima-Junior, Roberto C. P.
    Ribeiro, Ronaldo A.
    CLINICS, 2014, 69 (06) : 405 - 412
  • [4] The impact of renal function on the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with coronary artery disease
    Chen, Fei
    Li, Jia-qi
    Ou, Yuan-Wei-Xiang
    Xia, Tian-li
    Huang, Fang-yang
    Chai, Hua
    Huang, Bao-tao
    Li, Qiao
    Pu, Xiao-bo
    Li, Guo-yong
    Peng, Yong
    Chen, Mao
    Huang, De-jia
    CARDIOLOGY JOURNAL, 2019, 26 (06) : 696 - 703
  • [5] Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction
    Liebetrau, Christoph
    Gaede, Luise
    Doerr, Oliver
    Troidl, Christian
    Voss, Sandra
    Hoffmann, Jedrzej
    Paszko, Agata
    Weber, Michael
    Rolf, Andreas
    Hamm, Christian
    Nef, Holger
    Moellmann, Helge
    CLINICA CHIMICA ACTA, 2014, 429 : 34 - 37
  • [6] N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients
    Cosson, E.
    Nguyen, M. T.
    Pham, I.
    Pontet, M.
    Nitenberg, A.
    Valensi, P.
    DIABETIC MEDICINE, 2009, 26 (09) : 872 - 879
  • [7] Plasma N-terminal pro-B-type natriuretic peptide in the detection of aortic valve stenosis
    Koljonen, Elisa
    Lappalainen, Laura
    Kotiranta, Sanna
    Turpeinen, Anu
    Vepsalainen, Ville
    Karkkainen, Satu
    Romppanen, Jarkko
    Selander, Tuomas
    Hartikainen, Juha
    Rysa, Jaana
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2023, 83 (07) : 489 - 494
  • [8] N-Terminal Pro-B-Type Natriuretic Peptide and Subclinical Brain Damage in the General Population
    Zonneveld, Hazel I.
    Ikram, M. Arfan
    Hofman, Albert
    Niessen, Wiro J.
    van der Lugt, Aad
    Krestin, Gabriel P.
    Franco, Oscar H.
    Vernooij, Meike W.
    RADIOLOGY, 2017, 283 (01) : 205 - 214
  • [9] Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain
    Smedsrud, Marit Kristine
    Gravning, Jorgen
    Omland, Torbjorn
    Eek, Christian
    Morkrid, Lars
    Skulstad, Helge
    Aaberge, Lars
    Bendz, Bjorn
    Kjekshus, John
    Edvardsen, Thor
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2015, 31 (05) : 967 - 973
  • [10] N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN PATIENTS WITH HYPERTENSIVE HEART DISEASE
    Pejovic, Janko
    Ignjatovic, Svetlana
    Dajak, Marijana
    Majkic-Singh, Nada
    Vucinic, Zarko
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2011, 30 (03) : 244 - 249